Plain-English translation of NCT07266441 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Myeloma research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether , an experimental medication given as injections under the skin, can help people with multiple myeloma—a blood cancer affecting white blood cells—whose disease has returned or stopped responding to prior treatments. The researchers want to see how well this medication works for people who have already tried at least three other standard treatment approaches.
Multiple myeloma can be very difficult to treat, especially when it comes back or becomes resistant to standard therapies. This medication offers a new approach for patients who have exhausted other options, and researchers want to understand whether it can slow or shrink the cancer in these difficult-to-treat cases.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive injections of the experimental medication under your skin. The study will involve regular visits to the clinic where doctors will monitor how you're responding to the treatment, check for side effects, and do blood tests and other assessments. The exact length and frequency of visits will be explained to you, but you should expect ongoing appointments throughout your participation.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
United States